

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.26664125 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.26664125 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.94300635 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.94300635 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.60954498 |
| 6 | tryptophan catabolic process (GO:0006569) | 6.03251897 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 6.03251897 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 6.03251897 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.01645763 |
| 10 | bile acid biosynthetic process (GO:0006699) | 5.77889756 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.73869532 |
| 12 | tryptophan metabolic process (GO:0006568) | 5.68396724 |
| 13 | alpha-linolenic acid metabolic process (GO:0036109) | 5.49091372 |
| 14 | glyoxylate metabolic process (GO:0046487) | 5.47970038 |
| 15 | 4-hydroxyproline metabolic process (GO:0019471) | 5.41487104 |
| 16 | urea metabolic process (GO:0019627) | 5.29117430 |
| 17 | urea cycle (GO:0000050) | 5.29117430 |
| 18 | complement activation, alternative pathway (GO:0006957) | 5.26575106 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 5.22544354 |
| 20 | regulation of protein activation cascade (GO:2000257) | 5.20549637 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 5.19650850 |
| 22 | cysteine metabolic process (GO:0006534) | 5.14474554 |
| 23 | protein carboxylation (GO:0018214) | 5.12084959 |
| 24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.12084959 |
| 25 | peptidyl-proline hydroxylation (GO:0019511) | 5.10952277 |
| 26 | regulation of fibrinolysis (GO:0051917) | 5.07544091 |
| 27 | sulfur amino acid catabolic process (GO:0000098) | 5.07149180 |
| 28 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.89936314 |
| 29 | bile acid metabolic process (GO:0008206) | 4.86888611 |
| 30 | regulation of complement activation (GO:0030449) | 4.86365954 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 4.84424094 |
| 32 | aromatic amino acid family metabolic process (GO:0009072) | 4.81963182 |
| 33 | regulation of triglyceride catabolic process (GO:0010896) | 4.76874029 |
| 34 | tyrosine metabolic process (GO:0006570) | 4.73990108 |
| 35 | serine family amino acid catabolic process (GO:0009071) | 4.67147915 |
| 36 | reverse cholesterol transport (GO:0043691) | 4.57629925 |
| 37 | cellular ketone body metabolic process (GO:0046950) | 4.54117260 |
| 38 | acylglycerol homeostasis (GO:0055090) | 4.54059514 |
| 39 | triglyceride homeostasis (GO:0070328) | 4.54059514 |
| 40 | homocysteine metabolic process (GO:0050667) | 4.52551273 |
| 41 | regulation of cholesterol esterification (GO:0010872) | 4.48190011 |
| 42 | plasma lipoprotein particle remodeling (GO:0034369) | 4.47677812 |
| 43 | protein-lipid complex remodeling (GO:0034368) | 4.47677812 |
| 44 | macromolecular complex remodeling (GO:0034367) | 4.47677812 |
| 45 | phospholipid efflux (GO:0033700) | 4.45295318 |
| 46 | positive regulation of mitochondrial fission (GO:0090141) | 4.44491995 |
| 47 | alpha-amino acid catabolic process (GO:1901606) | 4.42643940 |
| 48 | lysine catabolic process (GO:0006554) | 4.40447514 |
| 49 | lysine metabolic process (GO:0006553) | 4.40447514 |
| 50 | coenzyme catabolic process (GO:0009109) | 4.38792356 |
| 51 | amino-acid betaine metabolic process (GO:0006577) | 4.37143286 |
| 52 | indolalkylamine metabolic process (GO:0006586) | 4.31419250 |
| 53 | bile acid and bile salt transport (GO:0015721) | 4.31144530 |
| 54 | protein hydroxylation (GO:0018126) | 4.12702785 |
| 55 | intestinal cholesterol absorption (GO:0030299) | 4.12415112 |
| 56 | plasma lipoprotein particle clearance (GO:0034381) | 4.11863131 |
| 57 | negative regulation of cholesterol transport (GO:0032375) | 4.11517038 |
| 58 | negative regulation of sterol transport (GO:0032372) | 4.11517038 |
| 59 | glutamate metabolic process (GO:0006536) | 4.09914351 |
| 60 | cellular biogenic amine catabolic process (GO:0042402) | 4.09536696 |
| 61 | amine catabolic process (GO:0009310) | 4.09536696 |
| 62 | cellular amino acid catabolic process (GO:0009063) | 4.08198941 |
| 63 | cellular glucuronidation (GO:0052695) | 4.05166421 |
| 64 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 4.04369494 |
| 65 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 4.04369494 |
| 66 | ketone body metabolic process (GO:1902224) | 3.98886818 |
| 67 | cholesterol efflux (GO:0033344) | 3.98718910 |
| 68 | imidazole-containing compound metabolic process (GO:0052803) | 3.95690189 |
| 69 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.95251002 |
| 70 | benzene-containing compound metabolic process (GO:0042537) | 3.94037479 |
| 71 | ethanol oxidation (GO:0006069) | 3.83244885 |
| 72 | fibrinolysis (GO:0042730) | 3.81886700 |
| 73 | cellular modified amino acid catabolic process (GO:0042219) | 3.81537721 |
| 74 | protein-lipid complex assembly (GO:0065005) | 3.78517358 |
| 75 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.76955475 |
| 76 | arginine metabolic process (GO:0006525) | 3.76173727 |
| 77 | glycine metabolic process (GO:0006544) | 3.75155076 |
| 78 | aldehyde catabolic process (GO:0046185) | 3.74916196 |
| 79 | serine family amino acid metabolic process (GO:0009069) | 3.74513951 |
| 80 | cytolysis (GO:0019835) | 3.71104538 |
| 81 | carboxylic acid catabolic process (GO:0046395) | 3.70544022 |
| 82 | organic acid catabolic process (GO:0016054) | 3.70544022 |
| 83 | complement activation, classical pathway (GO:0006958) | 3.69275604 |
| 84 | cofactor catabolic process (GO:0051187) | 3.68295105 |
| 85 | low-density lipoprotein particle remodeling (GO:0034374) | 3.68165853 |
| 86 | negative regulation of lipase activity (GO:0060192) | 3.67580754 |
| 87 | plasma lipoprotein particle assembly (GO:0034377) | 3.66601254 |
| 88 | uronic acid metabolic process (GO:0006063) | 3.65818490 |
| 89 | glucuronate metabolic process (GO:0019585) | 3.65818490 |
| 90 | positive regulation of lipid catabolic process (GO:0050996) | 3.64078703 |
| 91 | monocarboxylic acid catabolic process (GO:0072329) | 3.63974672 |
| 92 | complement activation (GO:0006956) | 3.63322805 |
| 93 | opsonization (GO:0008228) | 3.62508070 |
| 94 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.59398989 |
| 95 | acetyl-CoA metabolic process (GO:0006084) | 3.56789068 |
| 96 | protein activation cascade (GO:0072376) | 3.56197741 |
| 97 | phospholipid homeostasis (GO:0055091) | 3.56007052 |
| 98 | short-chain fatty acid metabolic process (GO:0046459) | 3.55441525 |
| 99 | COPII vesicle coating (GO:0048208) | 3.54565212 |
| 100 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.54524517 |
| 101 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.54524517 |
| 102 | short-term memory (GO:0007614) | 3.53789283 |
| 103 | drug catabolic process (GO:0042737) | 3.52767257 |
| 104 | plasma lipoprotein particle organization (GO:0071827) | 3.52638172 |
| 105 | negative regulation of protein activation cascade (GO:2000258) | 3.51482170 |
| 106 | blood coagulation, intrinsic pathway (GO:0007597) | 3.50804267 |
| 107 | serine family amino acid biosynthetic process (GO:0009070) | 3.47487779 |
| 108 | cholesterol homeostasis (GO:0042632) | 3.45880375 |
| 109 | fructose metabolic process (GO:0006000) | 3.45164904 |
| 110 | fatty acid beta-oxidation (GO:0006635) | 3.44817172 |
| 111 | glycolytic process (GO:0006096) | 3.43968532 |
| 112 | fatty acid oxidation (GO:0019395) | 3.43058975 |
| 113 | sterol homeostasis (GO:0055092) | 3.40605122 |
| 114 | fatty acid catabolic process (GO:0009062) | 3.38603580 |
| 115 | neurofilament cytoskeleton organization (GO:0060052) | 3.36316306 |
| 116 | glucose 6-phosphate metabolic process (GO:0051156) | 3.35888557 |
| 117 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.32076393 |
| 118 | C4-dicarboxylate transport (GO:0015740) | 3.31432019 |
| 119 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.28854689 |
| 120 | negative regulation of complement activation (GO:0045916) | 3.26647114 |
| 121 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 3.25621344 |
| 122 | L-ascorbic acid metabolic process (GO:0019852) | 3.15855256 |
| 123 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 3.15263581 |
| 124 | protein-lipid complex subunit organization (GO:0071825) | 3.14946467 |
| 125 | regulation of apoptotic cell clearance (GO:2000425) | 3.13412319 |
| 126 | regulation of plasminogen activation (GO:0010755) | 3.10670303 |
| 127 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.09940586 |
| 128 | * cholesterol biosynthetic process (GO:0006695) | 3.00300440 |
| 129 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.88114942 |
| 130 | artery smooth muscle contraction (GO:0014824) | 2.87281194 |
| 131 | photoreceptor cell differentiation (GO:0046530) | 2.80751521 |
| 132 | eye photoreceptor cell differentiation (GO:0001754) | 2.80751521 |
| 133 | membrane budding (GO:0006900) | 2.80221654 |
| 134 | pyruvate metabolic process (GO:0006090) | 2.78749633 |
| 135 | nucleobase catabolic process (GO:0046113) | 2.76860577 |
| 136 | nephron epithelium morphogenesis (GO:0072088) | 2.76584564 |
| 137 | nephron tubule morphogenesis (GO:0072078) | 2.76584564 |
| 138 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.75711440 |
| 139 | presynaptic membrane assembly (GO:0097105) | 2.74162569 |
| 140 | * sterol biosynthetic process (GO:0016126) | 2.73604519 |
| 141 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.70857578 |
| 142 | cholesterol transport (GO:0030301) | 2.65717235 |
| 143 | sterol transport (GO:0015918) | 2.65717235 |
| 144 | nonmotile primary cilium assembly (GO:0035058) | 2.64585455 |
| 145 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.63686889 |
| 146 | vascular smooth muscle contraction (GO:0014829) | 2.63510378 |
| 147 | regulation of mitochondrial fission (GO:0090140) | 2.61931246 |
| 148 | positive regulation of blood coagulation (GO:0030194) | 2.61119549 |
| 149 | positive regulation of hemostasis (GO:1900048) | 2.61119549 |
| 150 | peptidyl-glutamic acid modification (GO:0018200) | 2.54273431 |
| 151 | regulation of bile acid biosynthetic process (GO:0070857) | 2.50475055 |
| 152 | retinal ganglion cell axon guidance (GO:0031290) | 2.47936772 |
| 153 | regulation of branching involved in ureteric bud morphogenesis (GO:0090189) | 2.47088525 |
| 154 | regulation of hexokinase activity (GO:1903299) | 2.46273758 |
| 155 | regulation of glucokinase activity (GO:0033131) | 2.46273758 |
| 156 | intestinal absorption (GO:0050892) | 2.45879807 |
| 157 | presynaptic membrane organization (GO:0097090) | 2.45488998 |
| 158 | positive regulation of extracellular matrix organization (GO:1903055) | 2.44459812 |
| 159 | cellular sodium ion homeostasis (GO:0006883) | 2.41859465 |
| 160 | acute-phase response (GO:0006953) | 2.40414598 |
| 161 | response to pheromone (GO:0019236) | 2.39695607 |
| 162 | protein localization to cilium (GO:0061512) | 2.38400885 |
| 163 | negative regulation of coagulation (GO:0050819) | 2.37549992 |
| 164 | positive regulation of transforming growth factor beta production (GO:0071636) | 2.35674349 |
| 165 | positive regulation of coagulation (GO:0050820) | 2.35375890 |
| 166 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.35329342 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.37147467 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.27523938 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.12249277 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.77442560 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.79172800 |
| 6 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.26539478 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.22701914 |
| 8 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 4.04236513 |
| 9 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.83491059 |
| 10 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.65301960 |
| 11 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.31879348 |
| 12 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.06782118 |
| 13 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.63231175 |
| 14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.39934312 |
| 15 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.27048349 |
| 16 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.18974501 |
| 17 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.09569621 |
| 18 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.04238021 |
| 19 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.3673255 |
| 20 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.98841854 |
| 21 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.96444741 |
| 22 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.90394724 |
| 23 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.86995454 |
| 24 | FUS_26573619_Chip-Seq_HEK293_Human | 1.83960734 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.82977988 |
| 26 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.81594002 |
| 27 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.71430962 |
| 28 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.67675957 |
| 29 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.60471886 |
| 30 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.59090822 |
| 31 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.57696972 |
| 32 | EWS_26573619_Chip-Seq_HEK293_Human | 1.56329360 |
| 33 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.55633019 |
| 34 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.51194124 |
| 35 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.49244397 |
| 36 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.49207880 |
| 37 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.47332770 |
| 38 | * PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.46256473 |
| 39 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.44190615 |
| 40 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.43053365 |
| 41 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.42742308 |
| 42 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.42554843 |
| 43 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.40633459 |
| 44 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.40443500 |
| 45 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.39981368 |
| 46 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.38467778 |
| 47 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.38415223 |
| 48 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.38144764 |
| 49 | * TP53_16413492_ChIP-PET_HCT116_Human | 1.37810048 |
| 50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.37102372 |
| 51 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.36718717 |
| 52 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.35590716 |
| 53 | STAT3_23295773_ChIP-Seq_U87_Human | 1.35423250 |
| 54 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.30036127 |
| 55 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.28702215 |
| 56 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.28645512 |
| 57 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.26004955 |
| 58 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.25684155 |
| 59 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.25272607 |
| 60 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.25251693 |
| 61 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.25176096 |
| 62 | CJUN_26792858_Chip-Seq_BT549_Human | 1.23960019 |
| 63 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.22743221 |
| 64 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.22297795 |
| 65 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.21617134 |
| 66 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.20359620 |
| 67 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.19634086 |
| 68 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.18351314 |
| 69 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.18351314 |
| 70 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.18301459 |
| 71 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.15699353 |
| 72 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.14234705 |
| 73 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.13984592 |
| 74 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.13708235 |
| 75 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.13580686 |
| 76 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.12273700 |
| 77 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.10861776 |
| 78 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10489922 |
| 79 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.08792715 |
| 80 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.08602335 |
| 81 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.08140087 |
| 82 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.05857440 |
| 83 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05020881 |
| 84 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04809344 |
| 85 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.04332317 |
| 86 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.04082700 |
| 87 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.03116187 |
| 88 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.01851001 |
| 89 | TCF4_23295773_ChIP-Seq_U87_Human | 1.01385050 |
| 90 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.01305053 |
| 91 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.99666581 |
| 92 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.99107750 |
| 93 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97740342 |
| 94 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.95471349 |
| 95 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94693855 |
| 96 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.93276299 |
| 97 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.92779776 |
| 98 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.91034496 |
| 99 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.87704825 |
| 100 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.86377994 |
| 101 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.83271861 |
| 102 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.82548251 |
| 103 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81186899 |
| 104 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.80465509 |
| 105 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.78784829 |
| 106 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.76774158 |
| 107 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.76379315 |
| 108 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.76039472 |
| 109 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.73859933 |
| 110 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.73019309 |
| 111 | VDR_22108803_ChIP-Seq_LS180_Human | 0.71701659 |
| 112 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.71376868 |
| 113 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.70022904 |
| 114 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.69456181 |
| 115 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68625921 |
| 116 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.68423109 |
| 117 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.67609741 |
| 118 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.65709255 |
| 119 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.65137500 |
| 120 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.64630551 |
| 121 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.62321459 |
| 122 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.61290662 |
| 123 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.60475281 |
| 124 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.59902510 |
| 125 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.59537314 |
| 126 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.59150043 |
| 127 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.59087029 |
| 128 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.58968861 |
| 129 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.58036588 |
| 130 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.57795687 |
| 131 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.56432917 |
| 132 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.55684848 |
| 133 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.55658757 |
| 134 | AR_25329375_ChIP-Seq_VCAP_Human | 0.55212707 |
| 135 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.54752233 |
| 136 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.54300716 |
| 137 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.54300716 |
| 138 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.54289772 |
| 139 | * P300_19829295_ChIP-Seq_ESCs_Human | 0.54178256 |
| 140 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53805479 |
| 141 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.53395738 |
| 142 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.53304087 |
| 143 | * TCF4_22108803_ChIP-Seq_LS180_Human | 0.52458780 |
| 144 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.51862593 |
| 145 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.51724577 |
| 146 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.51406029 |
| 147 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.51231154 |
| 148 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.50703979 |
| 149 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.50581212 |
| 150 | CBP_21632823_ChIP-Seq_H3396_Human | 0.50432167 |
| 151 | * NCOR_22424771_ChIP-Seq_293T_Human | 0.50322914 |
| 152 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.50165728 |
| 153 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.50057453 |
| 154 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50022701 |
| 155 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.49973725 |
| 156 | AR_20517297_ChIP-Seq_VCAP_Human | 0.49831441 |
| 157 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.49824488 |
| 158 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.49774115 |
| 159 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.49709455 |
| 160 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49375884 |
| 161 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.49263825 |
| 162 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.48203460 |
| 163 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.46877714 |
| 164 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.46677085 |
| 165 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.46677085 |
| 166 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.46527772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.27341863 |
| 2 | MP0005360_urolithiasis | 7.06468042 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.37007134 |
| 4 | MP0005365_abnormal_bile_salt | 6.16905126 |
| 5 | MP0003122_maternal_imprinting | 5.92553442 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.76554883 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 4.02837372 |
| 8 | MP0003252_abnormal_bile_duct | 3.93322229 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.55942876 |
| 10 | MP0003195_calcinosis | 3.19695204 |
| 11 | MP0005083_abnormal_biliary_tract | 2.93443574 |
| 12 | MP0009840_abnormal_foam_cell | 2.78417238 |
| 13 | MP0003121_genomic_imprinting | 2.78128172 |
| 14 | MP0004272_abnormal_basement_membrane | 2.75466535 |
| 15 | MP0006054_spinal_hemorrhage | 2.74235861 |
| 16 | MP0003950_abnormal_plasma_membrane | 2.65578145 |
| 17 | MP0005332_abnormal_amino_acid | 2.65432772 |
| 18 | MP0001984_abnormal_olfaction | 2.63630856 |
| 19 | MP0001666_abnormal_nutrient_absorption | 2.57727105 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 2.26736539 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 2.11411658 |
| 22 | MP0004019_abnormal_vitamin_homeostasis | 2.06407438 |
| 23 | MP0000609_abnormal_liver_physiology | 2.05916629 |
| 24 | MP0003880_abnormal_central_pattern | 1.98763339 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 1.90861169 |
| 26 | MP0003868_abnormal_feces_composition | 1.90147767 |
| 27 | MP0005319_abnormal_enzyme/_coenzyme | 1.74479051 |
| 28 | MP0003123_paternal_imprinting | 1.73023242 |
| 29 | MP0001529_abnormal_vocalization | 1.63645553 |
| 30 | MP0008438_abnormal_cutaneous_collagen | 1.58603033 |
| 31 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57822382 |
| 32 | MP0009697_abnormal_copulation | 1.57588131 |
| 33 | MP0001764_abnormal_homeostasis | 1.51227310 |
| 34 | MP0003136_yellow_coat_color | 1.49169055 |
| 35 | MP0002938_white_spotting | 1.47782234 |
| 36 | MP0004270_analgesia | 1.42904158 |
| 37 | MP0002638_abnormal_pupillary_reflex | 1.40053211 |
| 38 | MP0002282_abnormal_trachea_morphology | 1.39145138 |
| 39 | MP0002233_abnormal_nose_morphology | 1.38862928 |
| 40 | MP0003890_abnormal_embryonic-extraembry | 1.35502249 |
| 41 | MP0000516_abnormal_urinary_system | 1.35493120 |
| 42 | MP0005367_renal/urinary_system_phenotyp | 1.35493120 |
| 43 | MP0005451_abnormal_body_composition | 1.32907942 |
| 44 | MP0005551_abnormal_eye_electrophysiolog | 1.26402506 |
| 45 | MP0003011_delayed_dark_adaptation | 1.26396272 |
| 46 | MP0005499_abnormal_olfactory_system | 1.24475104 |
| 47 | MP0005394_taste/olfaction_phenotype | 1.24475104 |
| 48 | MP0000372_irregular_coat_pigmentation | 1.24382262 |
| 49 | MP0002254_reproductive_system_inflammat | 1.24092624 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.22923376 |
| 51 | MP0003705_abnormal_hypodermis_morpholog | 1.21760865 |
| 52 | MP0000778_abnormal_nervous_system | 1.21557137 |
| 53 | MP0004142_abnormal_muscle_tone | 1.19529655 |
| 54 | MP0005257_abnormal_intraocular_pressure | 1.18619474 |
| 55 | MP0001915_intracranial_hemorrhage | 1.17184460 |
| 56 | MP0000604_amyloidosis | 1.14861162 |
| 57 | MP0009643_abnormal_urine_homeostasis | 1.14708283 |
| 58 | MP0005647_abnormal_sex_gland | 1.14314566 |
| 59 | MP0002837_dystrophic_cardiac_calcinosis | 1.13608185 |
| 60 | MP0004484_altered_response_of | 1.12730643 |
| 61 | MP0010386_abnormal_urinary_bladder | 1.10722543 |
| 62 | MP0002909_abnormal_adrenal_gland | 1.09628083 |
| 63 | MP0009780_abnormal_chondrocyte_physiolo | 1.08889147 |
| 64 | MP0003656_abnormal_erythrocyte_physiolo | 1.08760493 |
| 65 | MP0002876_abnormal_thyroid_physiology | 1.05228865 |
| 66 | MP0002557_abnormal_social/conspecific_i | 1.04422054 |
| 67 | MP0010368_abnormal_lymphatic_system | 1.03795034 |
| 68 | MP0003186_abnormal_redox_activity | 1.02392184 |
| 69 | MP0000598_abnormal_liver_morphology | 1.01496680 |
| 70 | MP0009046_muscle_twitch | 1.01452143 |
| 71 | MP0006072_abnormal_retinal_apoptosis | 1.00916134 |
| 72 | MP0001879_abnormal_lymphatic_vessel | 1.00058318 |
| 73 | MP0001286_abnormal_eye_development | 0.99740582 |
| 74 | MP0001324_abnormal_eye_pigmentation | 0.99697720 |
| 75 | MP0009764_decreased_sensitivity_to | 0.99398058 |
| 76 | MP0005410_abnormal_fertilization | 0.98397595 |
| 77 | MP0005636_abnormal_mineral_homeostasis | 0.98220499 |
| 78 | MP0000955_abnormal_spinal_cord | 0.92461471 |
| 79 | MP0003567_abnormal_fetal_cardiomyocyte | 0.90998751 |
| 80 | MP0000566_synostosis | 0.90857085 |
| 81 | MP0002078_abnormal_glucose_homeostasis | 0.88569596 |
| 82 | MP0002184_abnormal_innervation | 0.87997905 |
| 83 | MP0003221_abnormal_cardiomyocyte_apopto | 0.87463477 |
| 84 | MP0009763_increased_sensitivity_to | 0.86056624 |
| 85 | MP0005253_abnormal_eye_physiology | 0.85906407 |
| 86 | MP0009642_abnormal_blood_homeostasis | 0.84356001 |
| 87 | MP0001486_abnormal_startle_reflex | 0.84014962 |
| 88 | MP0004130_abnormal_muscle_cell | 0.83655818 |
| 89 | MP0008789_abnormal_olfactory_epithelium | 0.83472288 |
| 90 | MP0006036_abnormal_mitochondrial_physio | 0.82823266 |
| 91 | MP0005535_abnormal_body_temperature | 0.82625080 |
| 92 | MP0003942_abnormal_urinary_system | 0.82517969 |
| 93 | MP0005408_hypopigmentation | 0.82172430 |
| 94 | MP0004859_abnormal_synaptic_plasticity | 0.80610545 |
| 95 | MP0003329_amyloid_beta_deposits | 0.80267108 |
| 96 | MP0002822_catalepsy | 0.79013974 |
| 97 | MP0008469_abnormal_protein_level | 0.78490409 |
| 98 | MP0005084_abnormal_gallbladder_morpholo | 0.78331195 |
| 99 | MP0002971_abnormal_brown_adipose | 0.78160636 |
| 100 | MP0002132_abnormal_respiratory_system | 0.77947470 |
| 101 | MP0008995_early_reproductive_senescence | 0.77310119 |
| 102 | MP0001299_abnormal_eye_distance/ | 0.76659652 |
| 103 | MP0003315_abnormal_perineum_morphology | 0.76499508 |
| 104 | MP0005670_abnormal_white_adipose | 0.74739334 |
| 105 | MP0006035_abnormal_mitochondrial_morpho | 0.74287524 |
| 106 | MP0002102_abnormal_ear_morphology | 0.74185508 |
| 107 | MP0004742_abnormal_vestibular_system | 0.73300289 |
| 108 | MP0005376_homeostasis/metabolism_phenot | 0.73222132 |
| 109 | MP0001270_distended_abdomen | 0.72293401 |
| 110 | MP0005195_abnormal_posterior_eye | 0.71844995 |
| 111 | MP0005334_abnormal_fat_pad | 0.69917411 |
| 112 | MP0002067_abnormal_sensory_capabilities | 0.69010940 |
| 113 | MP0001293_anophthalmia | 0.68757454 |
| 114 | MP0000534_abnormal_ureter_morphology | 0.67400989 |
| 115 | MP0005386_behavior/neurological_phenoty | 0.67308074 |
| 116 | MP0004924_abnormal_behavior | 0.67308074 |
| 117 | MP0002736_abnormal_nociception_after | 0.67109500 |
| 118 | MP0005187_abnormal_penis_morphology | 0.66388789 |
| 119 | MP0002796_impaired_skin_barrier | 0.66265924 |
| 120 | MP0003937_abnormal_limbs/digits/tail_de | 0.65798715 |
| 121 | MP0005448_abnormal_energy_balance | 0.65631659 |
| 122 | MP0005167_abnormal_blood-brain_barrier | 0.64895326 |
| 123 | MP0005220_abnormal_exocrine_pancreas | 0.64565710 |
| 124 | MP0003690_abnormal_glial_cell | 0.64442797 |
| 125 | MP0003633_abnormal_nervous_system | 0.64044592 |
| 126 | MP0003755_abnormal_palate_morphology | 0.63165121 |
| 127 | MP0002734_abnormal_mechanical_nocicepti | 0.62356395 |
| 128 | MP0002697_abnormal_eye_size | 0.61798071 |
| 129 | MP0000639_abnormal_adrenal_gland | 0.59765759 |
| 130 | MP0009765_abnormal_xenobiotic_induced | 0.59736886 |
| 131 | MP0001756_abnormal_urination | 0.58019632 |
| 132 | MP0005266_abnormal_metabolism | 0.57181052 |
| 133 | MP0004782_abnormal_surfactant_physiolog | 0.54487047 |
| 134 | MP0001661_extended_life_span | 0.53193602 |
| 135 | MP0000579_abnormal_nail_morphology | 0.53039757 |
| 136 | MP0004381_abnormal_hair_follicle | 0.51446022 |
| 137 | MP0000427_abnormal_hair_cycle | 0.49592711 |
| 138 | MP0005395_other_phenotype | 0.47876089 |
| 139 | MP0009384_cardiac_valve_regurgitation | 0.47742194 |
| 140 | MP0002060_abnormal_skin_morphology | 0.47282168 |
| 141 | MP0002168_other_aberrant_phenotype | 0.45898838 |
| 142 | MP0005666_abnormal_adipose_tissue | 0.45647079 |
| 143 | MP0003953_abnormal_hormone_level | 0.45341721 |
| 144 | MP0008874_decreased_physiological_sensi | 0.44254733 |
| 145 | MP0000230_abnormal_systemic_arterial | 0.42560947 |
| 146 | MP0003724_increased_susceptibility_to | 0.41420603 |
| 147 | MP0004043_abnormal_pH_regulation | 0.41133074 |
| 148 | MP0003638_abnormal_response/metabolism_ | 0.40545764 |
| 149 | MP0009053_abnormal_anal_canal | 0.40538629 |
| 150 | MP0003075_altered_response_to | 0.40039567 |
| 151 | MP0005166_decreased_susceptibility_to | 0.39913870 |
| 152 | MP0010234_abnormal_vibrissa_follicle | 0.38232847 |
| 153 | MP0005248_abnormal_Harderian_gland | 0.37062706 |
| 154 | MP0002136_abnormal_kidney_physiology | 0.36775727 |
| 155 | MP0002090_abnormal_vision | 0.33407304 |
| 156 | MP0002928_abnormal_bile_duct | 0.33279510 |
| 157 | MP0004883_abnormal_blood_vessel | 0.33065919 |
| 158 | MP0008873_increased_physiological_sensi | 0.31560624 |
| 159 | MP0000249_abnormal_blood_vessel | 0.31175048 |
| 160 | MP0005595_abnormal_vascular_smooth | 0.30994478 |
| 161 | MP0006276_abnormal_autonomic_nervous | 0.30672832 |
| 162 | MP0001243_abnormal_dermal_layer | 0.29934030 |
| 163 | MP0005164_abnormal_response_to | 0.29219915 |
| 164 | MP0002295_abnormal_pulmonary_circulatio | 0.28438818 |
| 165 | MP0005464_abnormal_platelet_physiology | 0.28324506 |
| 166 | MP0001881_abnormal_mammary_gland | 0.28280582 |
| 167 | MP0001944_abnormal_pancreas_morphology | 0.28211684 |
| 168 | MP0005646_abnormal_pituitary_gland | 0.28028352 |
| 169 | MP0002970_abnormal_white_adipose | 0.27038554 |
| 170 | MP0004185_abnormal_adipocyte_glucose | 0.26969779 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.03237439 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.98359812 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.85409885 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.49365377 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.16299311 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.06667276 |
| 7 | Xanthomatosis (HP:0000991) | 6.02840330 |
| 8 | Abnormality of glycolysis (HP:0004366) | 5.58024149 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.51751789 |
| 10 | Increased serum pyruvate (HP:0003542) | 5.38263613 |
| 11 | Complement deficiency (HP:0004431) | 5.36995400 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.55757087 |
| 13 | Hyperammonemia (HP:0001987) | 4.51894416 |
| 14 | Epidermoid cyst (HP:0200040) | 4.51427773 |
| 15 | Conjugated hyperbilirubinemia (HP:0002908) | 4.40906609 |
| 16 | Joint hemorrhage (HP:0005261) | 4.36025492 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.34703111 |
| 18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.25424822 |
| 19 | Ketosis (HP:0001946) | 4.15546400 |
| 20 | Hypoglycemic coma (HP:0001325) | 4.10774660 |
| 21 | Fat malabsorption (HP:0002630) | 4.06329957 |
| 22 | Hyperglycinemia (HP:0002154) | 4.02424938 |
| 23 | Hypoalphalipoproteinemia (HP:0003233) | 4.00563815 |
| 24 | Abnormality of the intrinsic pathway (HP:0010989) | 3.95411236 |
| 25 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.91393728 |
| 26 | Abnormality of methionine metabolism (HP:0010901) | 3.89887117 |
| 27 | Abnormality of complement system (HP:0005339) | 3.84436702 |
| 28 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.82384131 |
| 29 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.80934800 |
| 30 | Small epiphyses (HP:0010585) | 3.71292319 |
| 31 | Abnormal tarsal ossification (HP:0008369) | 3.64068988 |
| 32 | Hyperglycinuria (HP:0003108) | 3.45152258 |
| 33 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.43054173 |
| 34 | Abnormality of glycine metabolism (HP:0010895) | 3.43054173 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.30813606 |
| 36 | Ketoacidosis (HP:0001993) | 3.24560435 |
| 37 | Hyperbilirubinemia (HP:0002904) | 3.23231828 |
| 38 | Hypercholesterolemia (HP:0003124) | 3.22917137 |
| 39 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.22886681 |
| 40 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.22243109 |
| 41 | Hypothermia (HP:0002045) | 3.18581967 |
| 42 | Exercise-induced muscle cramps (HP:0003710) | 3.14892069 |
| 43 | Spontaneous abortion (HP:0005268) | 3.09045735 |
| 44 | Systemic lupus erythematosus (HP:0002725) | 3.05356464 |
| 45 | Steatorrhea (HP:0002570) | 3.03816445 |
| 46 | Hypoglycemic seizures (HP:0002173) | 3.02948669 |
| 47 | Skin nodule (HP:0200036) | 2.90002351 |
| 48 | Broad alveolar ridges (HP:0000187) | 2.88518682 |
| 49 | Hepatocellular carcinoma (HP:0001402) | 2.87585880 |
| 50 | Abnormality of nucleobase metabolism (HP:0010932) | 2.85295165 |
| 51 | Epiphyseal dysplasia (HP:0002656) | 2.81279850 |
| 52 | Myocardial infarction (HP:0001658) | 2.80539688 |
| 53 | Delayed CNS myelination (HP:0002188) | 2.79973110 |
| 54 | Abnormality of serum amino acid levels (HP:0003112) | 2.77944397 |
| 55 | Vascular calcification (HP:0004934) | 2.74773696 |
| 56 | Medial flaring of the eyebrow (HP:0010747) | 2.73911014 |
| 57 | Abnormality of carpal bone ossification (HP:0006257) | 2.69390663 |
| 58 | Metabolic acidosis (HP:0001942) | 2.67572222 |
| 59 | Abnormality of purine metabolism (HP:0004352) | 2.66821193 |
| 60 | Action tremor (HP:0002345) | 2.66468825 |
| 61 | Congenital primary aphakia (HP:0007707) | 2.61926568 |
| 62 | Gait imbalance (HP:0002141) | 2.61812254 |
| 63 | Gout (HP:0001997) | 2.61348133 |
| 64 | Abnormal gallbladder morphology (HP:0012437) | 2.59468983 |
| 65 | Abnormal gallbladder physiology (HP:0012438) | 2.56113559 |
| 66 | Cholecystitis (HP:0001082) | 2.56113559 |
| 67 | Papillary thyroid carcinoma (HP:0002895) | 2.54083278 |
| 68 | Cholelithiasis (HP:0001081) | 2.53763993 |
| 69 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.53738670 |
| 70 | Cardiovascular calcification (HP:0011915) | 2.47956949 |
| 71 | Lethargy (HP:0001254) | 2.47710055 |
| 72 | Irregular epiphyses (HP:0010582) | 2.46623297 |
| 73 | Mitral stenosis (HP:0001718) | 2.45665780 |
| 74 | Abnormality of the wing of the ilium (HP:0011867) | 2.45154362 |
| 75 | Dicarboxylic aciduria (HP:0003215) | 2.44553435 |
| 76 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.44553435 |
| 77 | Nephrogenic diabetes insipidus (HP:0009806) | 2.44194457 |
| 78 | True hermaphroditism (HP:0010459) | 2.42861753 |
| 79 | Supernumerary spleens (HP:0009799) | 2.42686388 |
| 80 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.42076590 |
| 81 | Cerebral edema (HP:0002181) | 2.41680014 |
| 82 | Hypochromic microcytic anemia (HP:0004840) | 2.39635499 |
| 83 | Vaginal atresia (HP:0000148) | 2.39523248 |
| 84 | Genital tract atresia (HP:0001827) | 2.38040877 |
| 85 | Enlarged kidneys (HP:0000105) | 2.32428305 |
| 86 | Arterial tortuosity (HP:0005116) | 2.30950991 |
| 87 | Arthropathy (HP:0003040) | 2.28397505 |
| 88 | Sensorimotor neuropathy (HP:0007141) | 2.24102311 |
| 89 | Acanthocytosis (HP:0001927) | 2.23728448 |
| 90 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.23495403 |
| 91 | Abnormal hand bone ossification (HP:0010660) | 2.22071260 |
| 92 | Irritability (HP:0000737) | 2.21145185 |
| 93 | Neonatal onset (HP:0003623) | 2.20622839 |
| 94 | Postural tremor (HP:0002174) | 2.19342419 |
| 95 | Amyloidosis (HP:0011034) | 2.17173673 |
| 96 | Hepatoblastoma (HP:0002884) | 2.17069919 |
| 97 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.16621475 |
| 98 | Broad palm (HP:0001169) | 2.16221934 |
| 99 | Glomerulonephritis (HP:0000099) | 2.16069474 |
| 100 | Hyperventilation (HP:0002883) | 2.12782398 |
| 101 | Late onset (HP:0003584) | 2.12407681 |
| 102 | Spastic diplegia (HP:0001264) | 2.12116377 |
| 103 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.12012687 |
| 104 | Malnutrition (HP:0004395) | 2.11906895 |
| 105 | Abnormality of the gallbladder (HP:0005264) | 2.09556607 |
| 106 | Abnormal foot bone ossification (HP:0010675) | 2.09373474 |
| 107 | Symptomatic seizures (HP:0011145) | 2.09226656 |
| 108 | Proximal tubulopathy (HP:0000114) | 2.08929675 |
| 109 | Hypoplastic pelvis (HP:0008839) | 2.08275875 |
| 110 | Vomiting (HP:0002013) | 2.07895909 |
| 111 | Abnormality of the pubic bones (HP:0003172) | 2.07862967 |
| 112 | Pancreatitis (HP:0001733) | 2.07685853 |
| 113 | Brushfield spots (HP:0001088) | 2.06939185 |
| 114 | Gingival bleeding (HP:0000225) | 2.06872220 |
| 115 | Abnormality of proline metabolism (HP:0010907) | 2.06501162 |
| 116 | Vascular tortuosity (HP:0004948) | 2.04346778 |
| 117 | Atonic seizures (HP:0010819) | 2.02805098 |
| 118 | Generalized aminoaciduria (HP:0002909) | 2.02700633 |
| 119 | Rickets (HP:0002748) | 2.01907634 |
| 120 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.01819739 |
| 121 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.01819739 |
| 122 | Opisthotonus (HP:0002179) | 1.99112382 |
| 123 | Esophageal varix (HP:0002040) | 1.97778732 |
| 124 | Hyperglycemia (HP:0003074) | 1.97141623 |
| 125 | Back pain (HP:0003418) | 1.95473778 |
| 126 | Exotropia (HP:0000577) | 1.95472072 |
| 127 | Neuroendocrine neoplasm (HP:0100634) | 1.94120659 |
| 128 | Abnormality of the nasal septum (HP:0000419) | 1.93515320 |
| 129 | Broad foot (HP:0001769) | 1.93402323 |
| 130 | Metaphyseal irregularity (HP:0003025) | 1.91666445 |
| 131 | Focal motor seizures (HP:0011153) | 1.91169786 |
| 132 | Neonatal short-limb short stature (HP:0008921) | 1.90312503 |
| 133 | Fair hair (HP:0002286) | 1.90101787 |
| 134 | Thrombophlebitis (HP:0004418) | 1.90005116 |
| 135 | Renal cortical cysts (HP:0000803) | 1.89604242 |
| 136 | Hypophosphatemic rickets (HP:0004912) | 1.89517217 |
| 137 | Osteomalacia (HP:0002749) | 1.89004385 |
| 138 | Menorrhagia (HP:0000132) | 1.88817693 |
| 139 | Abnormality of urine glucose concentration (HP:0011016) | 1.87091547 |
| 140 | Glycosuria (HP:0003076) | 1.87091547 |
| 141 | Poor coordination (HP:0002370) | 1.85017524 |
| 142 | Thyroid carcinoma (HP:0002890) | 1.82975018 |
| 143 | Scrotal hypoplasia (HP:0000046) | 1.82768911 |
| 144 | Disproportionate short-trunk short stature (HP:0003521) | 1.81057866 |
| 145 | Status epilepticus (HP:0002133) | 1.81002268 |
| 146 | Decreased muscle mass (HP:0003199) | 1.80484952 |
| 147 | Hyperphosphaturia (HP:0003109) | 1.79671988 |
| 148 | Death in childhood (HP:0003819) | 1.77809913 |
| 149 | Pheochromocytoma (HP:0002666) | 1.76831218 |
| 150 | Bifid tongue (HP:0010297) | 1.76129498 |
| 151 | Anophthalmia (HP:0000528) | 1.76055735 |
| 152 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.76005640 |
| 153 | Increased purine levels (HP:0004368) | 1.75559265 |
| 154 | Hyperuricemia (HP:0002149) | 1.75559265 |
| 155 | Febrile seizures (HP:0002373) | 1.74501441 |
| 156 | Hydroxyprolinuria (HP:0003080) | 1.74138315 |
| 157 | Barrel-shaped chest (HP:0001552) | 1.72743631 |
| 158 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.70731809 |
| 159 | Absent epiphyses (HP:0010577) | 1.70731809 |
| 160 | Abnormal ossification of hand bones (HP:0005921) | 1.68595878 |
| 161 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.68006055 |
| 162 | Increased hepatocellular lipid droplets (HP:0006565) | 1.67004983 |
| 163 | Methylmalonic acidemia (HP:0002912) | 1.63831745 |
| 164 | Alacrima (HP:0000522) | 1.63049559 |
| 165 | Postaxial hand polydactyly (HP:0001162) | 1.62399180 |
| 166 | Hemiparesis (HP:0001269) | 1.59341986 |
| 167 | Pancreatic cysts (HP:0001737) | 1.57769887 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.92668050 |
| 2 | INSRR | 4.09953205 |
| 3 | FGFR4 | 3.68569621 |
| 4 | MAP4K2 | 3.48712586 |
| 5 | ERN1 | 3.46165086 |
| 6 | TNIK | 3.45094631 |
| 7 | SIK1 | 3.25586755 |
| 8 | EIF2AK3 | 2.98509440 |
| 9 | ERBB4 | 2.78737039 |
| 10 | TRIM28 | 2.64481797 |
| 11 | MAP2K4 | 2.57171455 |
| 12 | NEK1 | 2.56565896 |
| 13 | TAOK3 | 2.30536025 |
| 14 | MAPK11 | 2.24340964 |
| 15 | MST1R | 2.22331326 |
| 16 | MAP3K12 | 2.19505067 |
| 17 | PIK3CG | 2.18094287 |
| 18 | WNK4 | 2.13902970 |
| 19 | DAPK2 | 2.09427968 |
| 20 | ERBB3 | 2.07741452 |
| 21 | TYK2 | 2.07160676 |
| 22 | FGFR1 | 2.06706936 |
| 23 | STK39 | 1.94739606 |
| 24 | EPHA3 | 1.84070083 |
| 25 | FRK | 1.81396759 |
| 26 | WNK3 | 1.81105693 |
| 27 | MST4 | 1.61743370 |
| 28 | FLT3 | 1.61137018 |
| 29 | NEK9 | 1.59045738 |
| 30 | MAP3K9 | 1.58215439 |
| 31 | PLK2 | 1.54036807 |
| 32 | MARK1 | 1.53022545 |
| 33 | EIF2AK1 | 1.50599609 |
| 34 | PKN2 | 1.48171456 |
| 35 | PINK1 | 1.46310836 |
| 36 | LATS1 | 1.43499670 |
| 37 | STK24 | 1.41689476 |
| 38 | ARAF | 1.39887779 |
| 39 | NTRK2 | 1.30430124 |
| 40 | BMPR1B | 1.25380888 |
| 41 | FGFR2 | 1.19935938 |
| 42 | MAP3K2 | 1.19311529 |
| 43 | FER | 1.19108578 |
| 44 | EPHA4 | 1.14357312 |
| 45 | PDK3 | 1.11957114 |
| 46 | PDK4 | 1.11957114 |
| 47 | DYRK1B | 1.11501563 |
| 48 | SGK3 | 1.10438042 |
| 49 | MAP3K3 | 1.09972106 |
| 50 | MOS | 1.07630150 |
| 51 | MAP3K7 | 1.05404757 |
| 52 | SGK2 | 1.02268080 |
| 53 | DDR2 | 1.01684298 |
| 54 | PLK3 | 1.00180359 |
| 55 | MAP2K3 | 0.99493941 |
| 56 | JAK1 | 0.96280822 |
| 57 | JAK2 | 0.94799815 |
| 58 | ABL2 | 0.94238106 |
| 59 | YES1 | 0.93899186 |
| 60 | MAPK13 | 0.92368004 |
| 61 | PDK2 | 0.91155544 |
| 62 | STK38L | 0.90918733 |
| 63 | PTK6 | 0.89135036 |
| 64 | BRSK2 | 0.89053772 |
| 65 | CAMK2G | 0.87576941 |
| 66 | MAP3K14 | 0.87305134 |
| 67 | MINK1 | 0.87133965 |
| 68 | NTRK1 | 0.87012227 |
| 69 | SIK3 | 0.85429708 |
| 70 | OBSCN | 0.85022318 |
| 71 | PRKAA2 | 0.84235395 |
| 72 | RPS6KA4 | 0.83851696 |
| 73 | MAPK12 | 0.83173011 |
| 74 | NUAK1 | 0.82234884 |
| 75 | PRKCZ | 0.81357639 |
| 76 | SGK223 | 0.79695855 |
| 77 | SGK494 | 0.79695855 |
| 78 | IRAK3 | 0.79553165 |
| 79 | MAP2K7 | 0.77478990 |
| 80 | TRIB3 | 0.76840641 |
| 81 | MET | 0.75876803 |
| 82 | PRKACG | 0.75754939 |
| 83 | PAK3 | 0.74565285 |
| 84 | MAP2K1 | 0.74525286 |
| 85 | CASK | 0.71870287 |
| 86 | STK16 | 0.71011145 |
| 87 | ERBB2 | 0.68718357 |
| 88 | STK3 | 0.68667749 |
| 89 | MAPK15 | 0.68269092 |
| 90 | PRKCG | 0.65244991 |
| 91 | MAPK4 | 0.62303757 |
| 92 | MAP3K4 | 0.61344161 |
| 93 | PRKCQ | 0.60738194 |
| 94 | TBK1 | 0.60701908 |
| 95 | PIK3CA | 0.59717126 |
| 96 | KDR | 0.57423949 |
| 97 | MAPK7 | 0.56694626 |
| 98 | NLK | 0.56148499 |
| 99 | EPHB2 | 0.55880079 |
| 100 | FGFR3 | 0.55230416 |
| 101 | MYLK | 0.55102327 |
| 102 | MKNK2 | 0.54956175 |
| 103 | PDPK1 | 0.54647824 |
| 104 | GSK3A | 0.53036542 |
| 105 | AKT3 | 0.52167339 |
| 106 | WNK1 | 0.52119557 |
| 107 | MAP3K1 | 0.52057629 |
| 108 | KSR1 | 0.50799416 |
| 109 | CDK5 | 0.50792993 |
| 110 | TGFBR2 | 0.50187395 |
| 111 | LIMK1 | 0.50173067 |
| 112 | PRKAA1 | 0.49718600 |
| 113 | SRPK1 | 0.49665970 |
| 114 | TIE1 | 0.49556589 |
| 115 | ROCK2 | 0.49525499 |
| 116 | IGF1R | 0.49407627 |
| 117 | MAP2K6 | 0.48556068 |
| 118 | CSNK1G2 | 0.47885710 |
| 119 | CSNK1G1 | 0.47507259 |
| 120 | SIK2 | 0.47283588 |
| 121 | PTK2 | 0.47121350 |
| 122 | FGR | 0.46076727 |
| 123 | BRD4 | 0.45695562 |
| 124 | DYRK1A | 0.43951640 |
| 125 | MKNK1 | 0.42455298 |
| 126 | NEK2 | 0.42167894 |
| 127 | RET | 0.41512475 |
| 128 | PRKCH | 0.41004632 |
| 129 | GRK1 | 0.40450009 |
| 130 | CAMKK2 | 0.39476436 |
| 131 | VRK1 | 0.39413547 |
| 132 | OXSR1 | 0.38199440 |
| 133 | PKN1 | 0.37989555 |
| 134 | PRKG1 | 0.37429138 |
| 135 | CAMK1D | 0.36517726 |
| 136 | CSNK1G3 | 0.36311837 |
| 137 | CSNK1E | 0.35586556 |
| 138 | CAMK2A | 0.35331629 |
| 139 | LATS2 | 0.34981215 |
| 140 | TYRO3 | 0.34415740 |
| 141 | PRKCA | 0.33384414 |
| 142 | EPHB1 | 0.33038478 |
| 143 | CAMK4 | 0.32630716 |
| 144 | NTRK3 | 0.32169287 |
| 145 | DYRK2 | 0.32143131 |
| 146 | TAF1 | 0.31916491 |
| 147 | PRKCE | 0.31797366 |
| 148 | PRKACA | 0.31623908 |
| 149 | CDK18 | 0.31178663 |
| 150 | GRK6 | 0.30894963 |
| 151 | PDK1 | 0.30437677 |
| 152 | PTK2B | 0.29875479 |
| 153 | IRAK1 | 0.29686552 |
| 154 | PDGFRA | 0.29588904 |
| 155 | CDK6 | 0.29280695 |
| 156 | BCR | 0.28161214 |
| 157 | CSNK1A1L | 0.26416328 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.50567635 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.83288042 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.46635165 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.35122576 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.11487686 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.97593086 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.71486957 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.69817120 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68750370 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.55436837 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.53686354 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.43985626 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.36132299 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.24510284 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.17183619 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.08456459 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.07128356 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.06750861 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.91046336 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.89953479 |
| 21 | Retinol metabolism_Homo sapiens_hsa00830 | 1.89321721 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87195363 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.85045631 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.83037497 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.77006111 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.76216145 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.76048941 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.74662289 |
| 29 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.70312121 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.66492037 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.60386865 |
| 32 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.55563842 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.55235791 |
| 34 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.54944859 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.53686171 |
| 36 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.50949683 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49397819 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.46543202 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.46371677 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 1.43694784 |
| 41 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.42172931 |
| 42 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.36641848 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.33607547 |
| 44 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.23104897 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.22085662 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.19640218 |
| 47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.16647874 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.15300986 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.15189958 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.14288606 |
| 51 | Mineral absorption_Homo sapiens_hsa04978 | 1.10791540 |
| 52 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.09194511 |
| 53 | Proteasome_Homo sapiens_hsa03050 | 0.99677070 |
| 54 | Phototransduction_Homo sapiens_hsa04744 | 0.93186136 |
| 55 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.93070517 |
| 56 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.89799486 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.87864849 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86646956 |
| 59 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.86389604 |
| 60 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.82203322 |
| 61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81880065 |
| 62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.80782078 |
| 63 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.80485909 |
| 64 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.77857509 |
| 65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74824702 |
| 66 | Sulfur relay system_Homo sapiens_hsa04122 | 0.71699590 |
| 67 | Lysine degradation_Homo sapiens_hsa00310 | 0.69774726 |
| 68 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69242876 |
| 69 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.68118296 |
| 70 | Nicotine addiction_Homo sapiens_hsa05033 | 0.62663866 |
| 71 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60652614 |
| 72 | RNA degradation_Homo sapiens_hsa03018 | 0.59119430 |
| 73 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.58154866 |
| 74 | Basal transcription factors_Homo sapiens_hsa03022 | 0.56443553 |
| 75 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.54533397 |
| 76 | GABAergic synapse_Homo sapiens_hsa04727 | 0.48438191 |
| 77 | Parkinsons disease_Homo sapiens_hsa05012 | 0.47037053 |
| 78 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.46651450 |
| 79 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46419835 |
| 80 | Prion diseases_Homo sapiens_hsa05020 | 0.45340815 |
| 81 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.44362017 |
| 82 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42306537 |
| 83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.41990234 |
| 84 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.41084509 |
| 85 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.37759790 |
| 86 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32222349 |
| 87 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30554809 |
| 88 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.30171829 |
| 89 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.29845717 |
| 90 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27605004 |
| 91 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.26256934 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24215091 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.24186333 |
| 94 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.24180504 |
| 95 | Axon guidance_Homo sapiens_hsa04360 | 0.23853783 |
| 96 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.22772619 |
| 97 | Alzheimers disease_Homo sapiens_hsa05010 | 0.21843211 |
| 98 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.21839042 |
| 99 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.18651738 |
| 100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16279531 |
| 101 | Taste transduction_Homo sapiens_hsa04742 | 0.14850456 |
| 102 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.13832274 |
| 103 | Adherens junction_Homo sapiens_hsa04520 | 0.13409421 |
| 104 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.12432370 |
| 105 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.11738490 |
| 106 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.08256513 |
| 107 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.01882486 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01700241 |
| 109 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2120208 |
| 110 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.2025298 |
| 111 | Amoebiasis_Homo sapiens_hsa05146 | -0.2009647 |
| 112 | Lysosome_Homo sapiens_hsa04142 | -0.1956704 |
| 113 | Hepatitis C_Homo sapiens_hsa05160 | -0.1866566 |
| 114 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1838343 |
| 115 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1777673 |
| 116 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1566616 |
| 117 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1470104 |
| 118 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1375092 |
| 119 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1325289 |
| 120 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1325147 |
| 121 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1263336 |
| 122 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1157387 |
| 123 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1148231 |
| 124 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0838714 |
| 125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0784832 |
| 126 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0331600 |
| 127 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0185741 |

